Ocular Therapeutix Inc (OCUL) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $9.59
• Market Cap: $2.07B
• EPS: $-1.42
• 52-Week High: $16.44
• 52-Week Low: $5.79

Market Sentiment

Ocular Therapeutix Inc currently has a Bullish sentiment score of 0.19.

About Ocular Therapeutix Inc

Ocular Therapeutix, Inc. is a biopharmaceutical leader in the development and commercialization of groundbreaking therapies for ophthalmic diseases, utilizing its innovative bioresorbable hydrogel platform technology. Headquartered in Bedford, Massachusetts, the company is dedicated to meeting unmet medical needs in eye care through a robust pipeline of products designed to improve patient adherence and therapeutic effectiveness. With a strong emphasis on research and development, Ocular Ther...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Ocular Therapeutix Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OCUL pay dividends?

Ocular Therapeutix Inc (OCUL) does not currently pay a regular dividend.

What is OCUL's market cap?

Ocular Therapeutix Inc (OCUL) has a market capitalization of $2.07B with a current stock price of $9.59.